Cardiotrophic effects of protein kinase C ε: Analysis by in vivo modulation of PKCε translocation

Circulation Research

Volumn 86, Issue 11, 2000, Pages 1173-1179

  Mochly Rosen, Daria ^a   Wu, Guangyu ^b   Hahn, Harvey ^b   Osinska, Hanna ^b   Liron, Tamar ^a   Lorenz, John N ^b   Yatani, Atsuko ^c   Robbins, Jeffrey ^b   Dorn II, Gerald W ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Cardiac hypertrophy; Cardiomyopathy; Protein kinase C; Transgenic mouse

Indexed keywords

ACTIN; MYOSIN HEAVY CHAIN; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CELL SIZE; CONTROLLED STUDY; GENE TRANSLOCATION; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0034625662     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.86.11.1173     Document Type: Article

References (30)

1. 2+-sensitive isoforms in the failing human heart. Circulation. 1999;99:384-391.
2. Dunnmon PM, Iwaki K, Henderson SA, Sen A, Chien KR. Phorbol esters induce immediate-early genes and activate cardiac gene transcription in neonatal rat myocardial cells. J Mol Cell Cardiol. 1990;22:901-910.
3. Qiu Y, Ping P, Tang X-L, Manchikalapudi S, Rizvi A, Zhang J, Takano H, Wu WJ, Teschner S, Bolli R. Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that epsilon is the isoform involved. J Clin Invest. 1998;101:2182-2198.
4. Miyamae M, Rodriguez MM, Camacho SA, Diamond I, Mochly-Rosen D, Figueredo VM. Activation of ε protein kinase C correlates with a cardioprotective effect of regular ethanol consumption. Proc Natl Acad Sci U S A. 1998;95:8262-8267.
5. D'Angelo DD, Sakata Y, Lorenz JN, Boivin G, Walsh RA, Liggett SB, Dorn GW II. Transgenic Gαq overexpression induces cardiac contractile function in mice. Proc Natl Acad Sci U S A. 1997;94:8121-8126.
6. Disatnik MH, Buraggi G, Mochly-Rosen D. Localization of protein kinase C isozymes in cardiac myocytes. Exp Cell Res. 1994;210:287-297.
7. Mochly-Rosen D. Localization of protein kinases by anchoring proteins: a theme in signal transduction. Science. 1995;268:247-251.
8. Johnson JA, Gray MO, Chen C-H, Mochly-Rosen D. A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J Biol Chem. 1996;271:24962-24966.
9. Ron D, Mochly-Rosen D. An autoregulatory region in protein kinase C: the pseudoanchoring site. Proc Natl Acad Sci U S A. 1995;92:492-496.
10. Dorn GW II, Souroujon MC, Liron T, Chen C-H, Gray MO, Zhou HZ, Csukai M, Wu G, Lorenz JN, Mochly-Rosen D. Sustained in vivo cardiac protection by a rationally designed peptide that causes ε protein kinase C translocation. Proc Natl Acad Sci U S A. 1999;96:12798-12803.
11. Subramaniam A, Jones WK, Gulick J, Wert S, Neuman J, Robbins J. Tissue-specific regulation of the α-myosin heavy chain gene promoter in transgenic mice. J Biol Chem. 1991;266:24613-24620.
12. Sakata Y, Lorenz JN, Hoit BD, Liggett SB, Walsh RA, Dorn GW II. Decompensation of pressure overload hypertrophy in Gαq overexpressing mice. Circulation. 1998;97:1488-1495.
13. 2+ channels in mouse ventricular myocytes. Am J Physiol. 1997;273:C1666-C1672.
14. 1-adrenoceptors. Circ Res. 1995;76:335-342.
15. Arber S, Hunter JJ, Ross J Jr, Hongo M, Sansig G, Borg J, Perriard JC, Chien KR, Caroni P. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell. 1997;88:393-403.
16. 2 adrenergic receptor overexpression in mouse hearts: critical role for expression level. Circulation. 2000;101:1707-1714.
17. Sussman MA, Lim HW, Gude N, Taigen T, Olson EN, Robbins J, Colbert MC, Gualberto A, Wieczorek DF, Molkentin JD. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science. 1998;281: 1690-1693.
18. Hunter JJ, Tanaka N, Rockman HA, Ross J Jr, Chien KR. Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. J Biol Chem. 1995; 270:23173-23178.
19. Chien KR, Knowlton KU, Zhu H, Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J. 1991;5:3037-3046.
20. 2 isoform in myocardium causes cardiomyopathy. Proc Natl Acad Sci U S A. 1997;94:9320-9325.
21. Bowman JC, Steinberg SF, Jiang T, Geenen DL, Fishman GI, Buttrick PM. Expression of protein kinase Cβ in the heart causes hypertrophy in adult mice and sudden death in neonates. J Clin Invest. 1997;100: 2189-2195.
22. 2-adrenergic receptors differentially affects cardiac hypertrophy and function in Gαq overexpressing mice. Proc Natl Acad Sci U S A. 1999;96:6400-6405.
23. q interface to inhibit in vivo pressure overload myocardial hypertrophy. Science. 1998;280:574-577.
24. Offermanns S, Toombs CF, Hu Y-H, Simon MI. Defective platelet activation in Gαq deficient mice. Nature. 1997;389:183-186.
25. αq-mediated cardiac hypertrophy and ventricular dysfunction. Mol Pharmacol. 2000;57: 278-287.
26. Yatani A, Frank K, Sako H, Kranias EG, Dorn GW II. Cardiac-specific overexpression of Gαq alters excitation-contraction coupling in isolated cardiac myocytes. J Mol Cell Cardiol. 1999;7:1327-1326.
27. Gu X, Bishop SP. Increased protein kinase C and isozyme redistribution in pressure-overload cardiac hypertrophy in the rat. Circ Res. 1994;75: 926-931.
28. Schaible TF, Ciambrone GJ, Capasso JM, Scheuer J. Cardiac conditioning ameliorates cardiac dysfunction associated with renal hypertension in rats. J Clin Invest. 1984;73:1086-1094.
29. Fazio S, Sabatini D, Capaldo B, Vigorito C, Giobdano A, Guida R, Pardo F, Biondi B, Sacca L. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med. 1996;334:809-814.
30. Hongo M, Sentianin EM, Tanaka N, Mao L, McKirnan MD, Clark RG, Won W, Chien KR, Ross J Jr. Angiotensin II blockade followed by growth hormone as adjunctive therapy after experimental myocardial infarction. J Card Fail. 1998;4:213-224.